| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
29,776 |
28,687 |
$284K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,506 |
2,501 |
$185K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,017 |
6,916 |
$91K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
6,456 |
6,384 |
$47K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
483 |
483 |
$45K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,844 |
3,823 |
$26K |
| 87428 |
|
253 |
252 |
$15K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
282 |
282 |
$12K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
241 |
240 |
$8K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
943 |
556 |
$7K |
| 81002 |
|
3,800 |
3,750 |
$6K |
| 81025 |
|
1,856 |
1,841 |
$6K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
54 |
54 |
$295.02 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
32 |
32 |
$243.57 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
14 |
14 |
$89.51 |
| 82962 |
|
13 |
13 |
$17.73 |
| 3078F |
|
1,398 |
1,381 |
$0.00 |
| 3075F |
|
155 |
154 |
$0.00 |
| 1036F |
|
1,887 |
1,841 |
$0.00 |
| 3079F |
|
262 |
261 |
$0.00 |
| 3074F |
|
1,494 |
1,474 |
$0.00 |